Table II.
Performance characteristics of eADA in DBA patients vs. DBA relatives and Non-DBA patients and relatives
| Increased eADA† | Performance Characteristics | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| DBA patients | DBA relatives | Non-DBA patients | Non-DBA patients and relatives | OR | 95% CI | Sensitivity (%) | Specificity (%) | NPV (%) | PPV (%) |
| 31/37 | 5*/68 | 70 | 17–304 | 84 | 93 | 92 | 86 | ||
| 31/37 | 3/64 | 105 | 21–632 | 84 | 95 | 91 | 91 | ||
| 31/37 | 3/77 | 132 | 27–793 | 84 | 96 | 93 | 91 | ||
OR indicates odds ratio in favour of being a DBA patient; CI, confidence interval; NPV, negative predictive value; PPV, positive predictive value; DBA, Diamond-Blackfan anaemia; eADA, erythrocyte adenosine deaminase.
Data and number of patients of individuals with increased ADA/number analysed.
These individuals did not meet the diagnostic criteria of DBA as described in the methods section.